BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25561214)

  • 1. Conventional treatment of actinic keratosis: an overview.
    Peris K; Fargnoli MC
    Curr Probl Dermatol; 2015; 46():108-14. PubMed ID: 25561214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
    Samrao A; Cockerell CJ
    Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
    Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
    G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
    Gold MH
    J Drugs Dermatol; 2008 Jan; 7(1):23-5. PubMed ID: 18246694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment considerations in actinic keratosis.
    Goldenberg G
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of actinic keratosis: an update.
    Berman B; Amini S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of new treatment modalities for actinic keratosis.
    Berman B; Villa AM; Ramirez CC
    J Drugs Dermatol; 2006 Feb; 5(2):167-73. PubMed ID: 16485885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Herms F
    Ann Dermatol Venereol; 2019 May; 146 Suppl 2():IIS22-IIS30. PubMed ID: 31133226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and novel treatment options for actinic keratosis.
    Jorizzo JL
    J Cutan Med Surg; 2004; 8 Suppl 3():13-21. PubMed ID: 15647860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic keratosis - review for clinical practice.
    de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
    Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapies for actinic keratosis.
    Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
    Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of actinic keratosis].
    Isoherranen K; Koskenmies S; Overmark M; Ylitalo L; Saksela O; Pitkänen S
    Duodecim; 2015; 131(9):863-70. PubMed ID: 26237885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of actinic keratosis.
    Navarrete-Dechent C; Marghoob AA; Marchetti MA
    J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
    Gupta AK; Paquet M
    Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.
    Dirschka T; Gupta G; Micali G; Stockfleth E; Basset-Séguin N; Del Marmol V; Dummer R; Jemec GBE; Malvehy J; Peris K; Puig S; Stratigos AJ; Zalaudek I; Pellacani G
    J Dermatolog Treat; 2017 Aug; 28(5):431-442. PubMed ID: 27796187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.